74 related articles for article (PubMed ID: 7639005)
1. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer.
Yonemura Y; Ninomiya I; Kaji M; Sugiyama K; Fujimura K; Sawa T; Katayama K; Tanaka S; Hirono Y; Miwa K
World J Surg; 1995; 19(3):450-4; discussion 455. PubMed ID: 7639005
[TBL] [Abstract][Full Text] [Related]
2. Current Evidence for the Use of HIPEC and Cytoreductive Surgery in Gastric Cancer Metastatic to the Peritoneum.
Jain AJ; Badgwell BD
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892663
[TBL] [Abstract][Full Text] [Related]
3. A real-word study: is normothermic intraoperative intraperitoneal chemotherapy impactful as we expect?
Jin M; Cao W; Chen J; Xiong M; Cao G; Chen B
Front Oncol; 2023; 13():1172782. PubMed ID: 37469412
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)-a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO.
Di Giorgio A; Gerardi C; Abatini C; Melotti G; Bonavina L; Torri V; Santullo F; Garattini S; De Luca M; Rulli E; Rulli E; Pacelli F;
Trials; 2022 Dec; 23(1):969. PubMed ID: 36457115
[TBL] [Abstract][Full Text] [Related]
5. Role of prophylactic HIPEC in non-metastatic, serosa-invasive gastric cancer: a literature review.
Kunte AR; Parray AM; Bhandare MS; Solanki SL
Pleura Peritoneum; 2022 Sep; 7(3):103-115. PubMed ID: 36159214
[TBL] [Abstract][Full Text] [Related]
6. Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy.
Zeng L; Huang X; Tian Y; Huang J; Liu H; Wen J; Liu K; Shao Y; Luo J; Tang H; Liao Q; Lei Z; Cui W; Xia Q; Guan T; Li J; Cui S
Front Oncol; 2022; 12():796263. PubMed ID: 35350562
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic hyperthermic intraperitoneal chemotherapy may benefit the long-term survival of patients after radical gastric cancer surgery.
Zhuang X; He Y; Ma W
Sci Rep; 2022 Feb; 12(1):2583. PubMed ID: 35173230
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal chemotherapy in the treatment of gastric cancer peritoneal metastases: an overview of common therapeutic regimens.
Brandl A; Prabhu A
J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S32-S44. PubMed ID: 33968424
[TBL] [Abstract][Full Text] [Related]
9. How do we perform hyperthermic intraperitoneal chemotherapy in ovarian cancer? -a narrative review.
Ha HI; Lim MC
Gland Surg; 2021 Mar; 10(3):1235-1243. PubMed ID: 33842270
[TBL] [Abstract][Full Text] [Related]
10. Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
Rosa F; Galiandro F; Ricci R; Di Miceli D; Longo F; Quero G; Tortorelli AP; Alfieri S
Langenbecks Arch Surg; 2021 Sep; 406(6):1847-1857. PubMed ID: 33704561
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer-A Systematic Review.
Brenkman HJF; Päeva M; van Hillegersberg R; Ruurda JP; Haj Mohammad N
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31618869
[TBL] [Abstract][Full Text] [Related]
12. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
Desiderio J; Chao J; Melstrom L; Warner S; Tozzi F; Fong Y; Parisi A; Woo Y
Eur J Cancer; 2017 Jul; 79():1-14. PubMed ID: 28456089
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.
Yuan M; Wang Z; Hu G; Yang Y; Lv W; Lu F; Zhong H
Mol Clin Oncol; 2016 Aug; 5(2):395-399. PubMed ID: 27446587
[TBL] [Abstract][Full Text] [Related]
14. Recent developments and innovations in gastric cancer.
Mihmanli M; Ilhan E; Idiz UO; Alemdar A; Demir U
World J Gastroenterol; 2016 May; 22(17):4307-20. PubMed ID: 27158199
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.
Klaver CE; Musters GD; Bemelman WA; Punt CJ; Verwaal VJ; Dijkgraaf MG; Aalbers AG; van der Bilt JD; Boerma D; Bremers AJ; Burger JW; Buskens CJ; Evers P; van Ginkel RJ; van Grevenstein WM; Hemmer PH; de Hingh IH; Lammers LA; van Leeuwen BL; Meijerink WJ; Nienhuijs SW; Pon J; Radema SA; van Ramshorst B; Snaebjornsson P; Tuynman JB; Te Velde EA; Wiezer MJ; de Wilt JH; Tanis PJ
BMC Cancer; 2015 May; 15():428. PubMed ID: 26003804
[TBL] [Abstract][Full Text] [Related]
16. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial.
Rudloff U; Langan RC; Mullinax JE; Beane JD; Steinberg SM; Beresnev T; Webb CC; Walker M; Toomey MA; Schrump D; Pandalai P; Stojadinovic A; Avital I
J Surg Oncol; 2014 Sep; 110(3):275-84. PubMed ID: 25042700
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal carcinomatosis.
Coccolini F; Gheza F; Lotti M; Virzì S; Iusco D; Ghermandi C; Melotti R; Baiocchi G; Giulini SM; Ansaloni L; Catena F
World J Gastroenterol; 2013 Nov; 19(41):6979-94. PubMed ID: 24222942
[TBL] [Abstract][Full Text] [Related]
18. Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis.
Magge D; Zenati M; Mavanur A; Winer J; Ramalingam L; Jones H; Zureikat A; Holtzman M; Lee K; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2014 May; 21(5):1448-55. PubMed ID: 24197761
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy.
Lee JH; Son SY; Lee CM; Ahn SH; Park DJ; Kim HH
Gastric Cancer; 2014; 17(3):529-36. PubMed ID: 24101155
[TBL] [Abstract][Full Text] [Related]
20. A proposal of a practical and optimal prophylactic strategy for peritoneal recurrence.
Kuramoto M; Shimada S; Ikeshima S; Matsuo A; Kuhara H; Eto K; Baba H
J Oncol; 2012; 2012():340380. PubMed ID: 22481921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
